Fas Receptor: An Overview
DOI:
https://doi.org/10.17140/DRMTOJ-1-117Keywords:
Apoptosis, FasL, Fas, TNF-α, Death receptorAbstract
The FAS receptor (FasR), also known as apoptosis antigen 1 (APO-1 or APT), cluster of differentiation
95 (CD95) or tumor necrosis factor receptor superfamily 6 (TNFRSF6) is a protein
that in humans is encoded by the FAS gene. Engagement of the cell death surface receptor Fas
by Fas ligand (FasL) results in apoptotic cell death, mediated by caspase activation. Cell death
mediated via Fas/FasL interaction is important for homeostasis of different cell types. In this
review, we want to highlight the role of Fas receptor in different dermatologic disorders. This
would definitely help our understanding of its important role in dermatology that can open a
new era in using anti-Fas biologic therapy in the future management of such disorders.
References
Elgert KD. Immunologic tolerance and autoimmunity. Immu-nology: Understanding the Immune System. New York, USA: Wiley; 2009; 431-460.
Hotchkiss RS, Strasser A, McDunn JE, et al. Cell death. N Engl J Med. 2009; 36: 1570-1583.
Wajant H. Principles and mechanisms of CD95 activation. Biol Chem. 2014; 395(12): 1401-1416. doi: 10.1515/hsz-2014- 0212
Ashkenazi A, Dixit VM. Apoptosis control by death and de-coy receptors. Curr Opin Cell Biol. 1999; 11: 255-260.
Cascino I, Fiucci G, Papoff G, Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol. 1995; 154(6): 2706- 2713. Web site. http://www.jimmunol.org/content/154/6/2706. short. Accessed October 9, 2016.
Aggarwal BB. Signalling pathways of the TNF super family: a double-edged sword. Nat Rev Immunol. 2003; 3: 745-756. doi: 10.1038/nri1184
Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, Gores GJ. Bile salts mediate hepatocyte apoptosis by increasing cell sur-face trafficking of Fas. Am J Physiol Gastrointest Liver Physiol. 2000; 278(6): G992-G999. Web site. http://ajpgi.physiology.org/ content/278/6/G992.short. Accessed October 9, 2016.
Feng G, Kaplowitz N. Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody. J Clin Invest. 2000; 105(3): 329-339. Web site. http://www.jci.org/articles/ view/7398. Accessed October 9, 2016.
Peter ME, Hellbardt S, Schwartz-Albiez A, et al. Cell sur-face sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. Cell Death Differ. 1995; 2(3): 163-171. Web site. http://europepmc.org/abstract/ med/17180039. Accessed October 9, 2016.
Chan H, Bartos DP, Owen-Schaub LB. Activation dependent transcriptional regulation of the human Fas promoter requires NF-kappaB recruitment. Mol Cell Biol. 1999; 19(3): 2098-2108. doi: 10.1128/MCB.19.3.2098
Muller M, Wilder S, Bannasch D, et al. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by an-ticancer drugs. J Exp Med. 1998; 188(11): 2033-2045. doi: 10.1084/jem.188.11.2033
Trautmann A, Akdis M, Kleemann D, et al. T-cell mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest. 2000; 106(1): 25- 35. Web site. http://www.jci.org/articles/view/9199. Accessed October 9, 2016.
Simon D, Lindberg RL, Kozlowski E, Braathen LR, Simon HU. Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis le-sions. Exp Dermatol. 2006; 15(6): 441-446. doi: 10.1111/j.0906- 6705.2006.00428.x
Armbruster N, Trautmann A, Bröcker EB, Leverkus M, Ker-stan A. Suprabasal spongiosis in acute eczematous dermatitis: cFLIP maintains resistance of basal keratinocytes to T-cell-me-diated apoptosis. J Invest Dermatolol. 2009; 129(7): 1696-1702. doi: 10.1038/jid.2008.438
Siegel RM, Frederiksen JK, Zacharias DA, et al. Fas preas-sociation required for apoptosis signaling and dominant inhibi-tion by pathogenic mutations. Science. 2000; 288(5475): 2354- 2357. doi: 10.1126/science.288.5475.2354
Mollinedo F, Gajate C. FasL-independent activation of Fas. In: Wajant H, Ed. Fas Signaling. Germany: FEBS J; 276: 6912- 6927.
Krammer PH, Arnold R, Lavrik IN. Life and death in periph-eral T cells. Nat Rev Immunol. 2007; 7: 532-542. doi: 10.1038/ nri2115
Sprick M, Rieser E, Stahl H, et al. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signaling complexes in a FADD-dependent manner but cannot functionally substitute caspase-8. EMBO J. 2002; 21(17): 4520- 4530. doi: 10.1093/emboj/cdf441
Donepudi M, Mac Sweeney A, Briand C, et al. Insights into the regulatory mechanism for caspase-8 activation. Mol Cell. 2003; 11(2): 543-549. doi: 10.1016/S1097-2765(03)00059-5
Saratoy S, Badrawy T, Koth S. Expression of CD95 (FAS/ APO-1) in Non-Hodgkin Lymphoma. E J Surg. 2002; 21(3): 963-969.
Udritioiu A, Illiescu RG, Udristioiu L, et al. A new approach of abnormal apoptosis as a cause of autoimmunity and malig-nancy. Biotechnology and Molecular Biology Review. 2011; 6(8): 166-171. Web site. http://www.academicjournals.org/jour-nal/BMBR/article-abstract/E470D7A11833. Accessed October 9, 2016.
Warrell DA, Cox TM, John D. Apoptosis in health and dis-eases. In: Andrew H, Wyllie J, Mark J, eds. Oxford Textbook of Medicine. Oxford Medica; 2003; 4: 121-128.
Yap AS, Brieher WM, Gumbiner BM. Structure and func-tions of classical cadherins. Ann Rev Cell Dev Biol. 1997; 13: 119-146
Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J. 2009; 23(6): 1625-1637. doi: 10.1096/fj.08-111005
Ottonello L, Tortolina G, Amelotti M, Dallegri F. Soluble Fas ligand is chemotactic for human neutrophilic polymorpho-nuclear leukocytes. J Immunol. 1999; 162(6): 3601-3606. Web site. http://www.jimmunol.org/content/162/6/3601.long. Ac-cessed October 9, 2016.
Kischkel FC, Hellbardt S, Behrmann I, et al. Cytotoxicity dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995; 14(22): 5579-5588.
Strasser A, Pellegrini M. T-lymphocyte death during shut-down of an immune response. Trends Immunol. 2004; 25(11): 610-615. doi: 10.1016/j.it.2004.08.012
Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human fas ligand in activated lym-phocytes. EMBO J. 1995; 14(6): 1129-1135.
Takahashi T, Tanaka M, Brannan CI, et al. Generalized lym-phoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994; 76: 969-976. doi: 10.1016/0092- 8674(94)90375-1
Shudo K, Kinoshita K, Imamura R, et al. The membrane bound but not the soluble form of human Fas ligand is respon-sible for its inflammatory activity. Eur J Immunol. 2001; 31(8): 2504-2511. doi: 10.1002/1521-4141(200108)31:8<2504::AID-IMMU2504>3.0.CO;2-C
Schneider P, Holler N, Bodmer JL, et al. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is as-sociated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med. 1998; 187(8): 1205-1213. doi: 10.1084/jem.187.8.1205
Aoki K, Kurooka M, Chen JJ, Petryniak J, Nabel EG, Nabel GJ. Extracellular matrix interacts with soluble CD95L: Reten-tion and enhancement of cytotoxicity. Nat Immunol. 2001; 2: 333-337. doi: 10.1038/86336
Elgert KD. Tumor immunology. Immunology: Understand-ing the Immune System. 2nd ed. New York, USA: Wiley-Black-well; 2009: 489-528.
Hughes R, Collins P, Rogers S. Further experience of us-ing azathioprine in the treatment of severe atopic dermatitis. Clin Exp Dermatol. 2008; 33(6): 710-711. doi: 10.1111/j.1365- 2230.2008.02832.x
Turbyville JC, Rao VK. The autoimmune lymphoprolifera-tive syndrome: A rare disorder providing clues about normal tol-erance. Autoimmun Rev. 2010; 9(7): 488-493.
Martin R. Cell suicide for beginners. Nature. 1998; 396(6707): 119-122. doi: 10.1038/24055
Elgert KD. Cellular interactions: Development of effector functions and their regulation. Immunology: Understanding the Immune System. New York, USA; Wiley-Blackwell; 2009; 321- 368.
Peter ME, Legembre P, Barnhart BC. Does CD95 have tumor promoting activities? Biochim Biophys Acta. 2005; 1755(1): 25- 36. doi: 10.1016/j.bbcan.2005.01.001
Neumann L, Pforr C, Beaudouin J, et al. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol Syst Biol. 2010; 6: 352. doi: 10.1038/msb.2010.6
O’Reilly LA, Tai L, Lee L, et al. Membrane-bound Fas li-gand only is essential for Fas-induced apoptosis. Nature. 2009; 461(7264): 659-663. doi: 10.1038/nature08402
Lavrik IN, Krammer PH. Regulation of CD95/Fas signal-ing at the DISC. Cell Death Differ. 2012; 19(1): 36-41. doi: 10.1038/cdd.2011.155
Schütz C, Oelke M, Schneck JP, Mackensen A, Fleck M. Killer artificial antigen presenting cells: The synthetic embodi-ment of a ‘guided missile’. Immunotherapy. 2010; 2(4): 539- 550. doi: 10.2217/imt.10.26
Kay RA. The principles of adaptative immunity. In: Hoch-berg MC, Silman AJ, Smolen JS, Weinblatt ME, Wisman MH, eds. Rheumatology. Edinburgh, Scotland: Mosby; 2003: 113- 126.
Ottonello L, Tortolina G, Amelotti M, Dallegri F. Soluble Fas ligand is chemotactic for human neutrophilic polymorpho-nuclear leukocytes. J Immunol. 1999; 162(6): 3601-3606. Web site. http://www.jimmunol.org/content/162/6/3601.long. Ac-cessed October 9, 2016.
Kiener PA, Davis PM, Starling GC, et al. Differential induc-tion of apoptosis by Fas-Fas ligand interactions in human mono-cytes and macrophages. J Exp Med. 1997; 185(8): 1511-1516. doi: 10.1084/jem.185.8.1511
Lenardo MJ. Fas and the art of lymphocyte maintenance. J Exp Med. 1996; 183(3): 721-724. doi: 10.1084/jem.183.3.721
Goebeler M, Trautmann A, Voss A, Bröcker EV, Toksoy A, Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitiv-ity. Am J Pathol. 2001; 158(2): 431-440. doi: 10.1016/S0002- 9440(10)63986-7
Thepen T, Langeveld-Wildschut EG, Bihari IC, et al. Bipha-sic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: An immunocytochemical study. J Allergy Clin Immunol. 1996; 97(3): 828-837. doi: 10.1016/S0091-6749(96)80161-8
Konur A, Schulz U, Eissner G, et al. Interferon (IFN)-gam-ma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis fac-toralpha production. Br J Dermatol. 2005; 152(6): 1134-1142. doi: 10.1111/j.1365-2133.2005.06508.x
De Vries IJ, Langeveld-Wildschut EG, van Reijsen FC, et al. Adhesion molecule expression on skin endothelia in atopic der-matitis: effects of TNF-alpha and IL-4. J Allergy Clin Immunol. 1998; 102(3): 461-468. doi: 10.1016/S0091-6749(98)70136-8
Sayama K, Yonehara S, Watanabe Y, Miki Y. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J Invest Dermat. 1994; 103(3): 330- 334. doi: 10.1111/1523-1747.ep12394858
Norris DA, Middleton MH, Whang K, et al. Human kera-tinocytes maintain reversible anti-apoptotic defenses in vivo and in vitro. Apoptosis. 1977; 2(2): 136-148. doi: 10.1023 /A:1026456229688
Vaux DL, Silke J. IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol. 2005; 6: 287-297. doi: 10.1038/nrm1621
Schwarz EM, Lu AP, Goater JJ, et al. Tumor necrosis factor-α/nuclear transcription factor-κB signaling in peripros-thetic osteolysis. J Orthop Res. 2000; 18(3): 472-480. doi: 10.1002/jor.1100180321
Matsue H, Kobayashi H, Hosokawa T, et al. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN-g cultured keratinocytes. Arch Dermatol Res. 1995; 287(3- 4): 315-320.
Romagnani S. The Th1/Th2 paradigm. Immunol Today. 1997; 18(6): 263-266. doi: 10.1016/S0167-5699(97)80019-9
Chernyshov PV. Gender differences in health-related and family quality of life in young children with atopic dermati-tis. Int J Dermatol. 2012; 51(3): 290-294. doi: 10.1111/j.1365- 4632.2011.04997.x
Martin SF. Contact dermatitis, from pathomechanisms to immunotoxicology. Exp Dematol. 2012; 21(5): 382-389. doi: 10.1111/j.1600-0625.2012.01471.x
Sekine C, Yagita H, Kobata T, et al. Fas-mediated stimula-tion induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis. Biochem Biophys Res Commun. 1996; 228(1): 14-20. doi: 10.1006/bbrc.1996.1610
Peter ME, Krammer PH. Mechanisms of CD95 (APO-1/ Fas)-mediated apoptosis. Curr Opin Immunol. 1998; 10: 545- 551. doi: 10.1016/S0952-7915(98)80222-7
Takahashi H, Tsuji H, Honma M, et al. Japanese patients with psoriasis and atopic dermatitis show distinct personality profiles. J Dermatol. 2013; 370-373. doi: 10.1111/1346-8138.12087
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Dermatology (DER) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
